PRINCE试验:远程缺血预适应减少非心脏手术心肌损伤的启示
PRINCE试验是一项跨国双盲研究,将1213例非心脏手术患者随机分为远程缺血预适应(RIPC)组或假RIPC组,术后心肌损伤(高敏肌钙蛋白超过参考值第99百分位数)发生率分别为38.0%与37.4%,未显示RIPC获益。本文讨论试验特异性与机制性原因解释文献矛盾,认为RIPC减少非心脏手术器官损伤的作用仍有可能。
要点
- RIPC未显著降低非心脏手术术后心肌损伤发生率。
- 术后心肌损伤定义:高敏肌钙蛋白超过参考值第99百分位数。
- RIPC围术期器官保护作用仍待进一步研究。
核心结论
- PRINCE试验未显示RIPC降低非心脏手术术后心肌损伤,但RIPC减少器官损伤的作用仍有可能。
研究设计与样本
- PRINCE试验为跨国双盲随机对照试验,纳入1213例非心脏手术患者,随机接受RIPC或假RIPC。
主要发现
- 术后心肌损伤在RIPC组发生215/566例(38.0%),假RIPC组223/596例(37.4%)。
关键数值与推荐
- 术后心肌损伤定义为术后高敏肌钙蛋白超过参考值最高第99百分位数。
临床怎么用
- 基于PRINCE试验结果,RIPC不应常规用于非心脏手术以减少心肌损伤。
局限性
- 本文未报告PRINCE试验的样本量计算依据、P值及置信区间等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The remote ischemic PReconditioning In Non-Cardiac surgEry (PRINCE) trial was a multinational, double-blind trial in which 1213 patients undergoing noncardiac surgical procedures were randomly assigned to receive remote ischaemic preconditioning (RIPC) or sham-RIPC after general anaesthesia and before surgery to reduce myocardial injury. Postoperative myocardial injury, defined alone by postoperative high-sensitivity troponin above the highest 99th percentile of reference values, occurred in 215/566 patients (38.0%) in the RIPC group and in 223/596 patients (37.4%) in the sham-RIPC group. The PRINCE trial adds to an apparently contradictory literature on the role of RIPC in perioperative medicine. We discuss both trial-specific and mechanistic reasons to explain these discrepancies, and we contend that a role for RIPC in minimising organ injury as a result of noncardiac surgery remains possible.
引用
- Ackland GL, Pinto BB. The PRINCE trial of remote ischaemic preconditioning in noncardiac surgery to reduce myocardial injury: sign o' the times. Br J Anaesth. 2025. PMID: 41350217. doi:10.1016/j.bja.2025.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。